Clinical Trials for Marginal Zone Lymphoma

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

NCT ID: NCT04775745

This clinical trial is studying a new medication called LP-168, which is being tested for patients with certain types of blood cancers known as B-cell malignancies, including chronic lymphocytic le...

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

NCT ID: NCT04491370

This clinical trial is studying a new treatment approach for patients with certain types of B-cell lymphomas and Hodgkin lymphoma. Participants will first undergo a procedure called autologous stem...

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

NCT ID: NCT05923502

The CHANT study is looking into the use of Duvelisib, a medication in capsule form, for treating various types of non-Hodgkin's lymphoma (NHL), which is a type of cancer that affects the lymphatic ...

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma

NCT ID: NCT05846750

This clinical trial is studying the combination of two medications, obinutuzumab and lenalidomide, to see how effective they are in treating patients with relapsed or refractory marginal zone lymph...

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

NCT ID: NCT04911478